Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury

Heart

Volumn 99, Issue 11, 2013, Pages 805-810

  Davis, Sarah ^a   Westby, Maggie ^b   Petkar, Sanjiv ^c   Pitcher, David ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c NEW CROSS HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; FAINTNESS; HEART PACING; HUMAN; IMPLANTABLE CARDIAC MONITOR; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RISK ASSESSMENT; TILTING; UNCONSCIOUSNESS;

CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EQUIPMENT FAILURE; HUMANS; MODELS, ECONOMIC; MONITORING, PHYSIOLOGIC; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; RISK FACTORS; SYNCOPE, VASOVAGAL;

EID: 84877627966     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302851     Document Type: Article

References (15)

1. Westby M, Davis S, Bullock I, et al. Transient loss of consciousness ('blackouts') management in adults and young people. London: National Clinical Guideline Centre for Acute and Chronic Conditions, Royal College of Physicians, 2010. http://guidance.nice.org.uk/CG109 (accessed 1 Sep. 2011).
2. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.
3. Brignole M, Sutton R, Menozzi C, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 2006;27:2232-9. (Pubitemid 44412839)
4. Parry SW, Matthews IG. Implantable loop recorders in the investigation of unexplained syncope: a state of the art review. Heart 2010;96:1611-16.
5. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence, 2008.
6. Davis S, Westby M, Pitcher D, et al. Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained. Europace 2012;14:402-9.
7. Department of Health. NHS reference costs 2007-08. London: Department of Health, 2009.
8. National Horizon Scanning Centre. Reveal plus implantable loop recorders for the investigation of syncope and other events-Horizon Scanning review. Birmingham, UK: National Horizon Scanning Centre, 2004.
9. Personal Social Services Research Unit (PSSRU). Unit cost of health and social care 2008. Kent, UK: Personal Social Services Research Unit, 2008.
10. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). BMJ 1980;280:139-41. (Pubitemid 10215108)
11. Shaw DB, Kekwick CA, Veale D, et al. Survival in second degree atrioventricular block. Br Heart J 1985;53:587-93. (Pubitemid 15069658)
12. Castelnuovo E, Stein K, Pitt M, et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess 2005;9.
13. Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome. The THEOPACE Study: a randomized controlled trial. Circulation 1997;96:260-6. (Pubitemid 27298430)
14. Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with suspected neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012;125:2566-71.
15. Buxton M, Caine N, Chase D, et al. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Health Technol Assess 2006;10.